Showing results (1-10 of 314) with videos related to
Sort By:
Pageof 32
Calcified Tissue International|May 14, 2017
Bone Loss After Denosumab: Only Partial Protection with ZoledronateIan R Reid, Anne M Horne, Borislav Mihov, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 21, 2023
No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older WomenIan R Reid, Anne M Horne, Borislav Mihov, et al.Calcified Tissue International|March 13, 2021
Effect of Zoledronate on Lower Respiratory Infections in Older Women: Secondary Analysis of a Randomized Controlled TrialIan R Reid, Anne M Horne, Borislav Mihov, et al.Calcified Tissue International|January 4, 2020
Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled TrialIan R Reid, Anne M Horne, Borislav Mihov, et al.The Lancet. Diabetes & Endocrinology|March 7, 2024
Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 yearsIan R Reid, Anne M Horne, Borislav Mihov, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 22, 2026
Decreased Nonvertebral Fracture Incidence with Zoledronate Use For >3 Years: Post Hoc Analysis of an RCTIan R Reid, Anne M Horne, Borislav Mihov, et al.Calcified Tissue International|February 16, 2018
Bone Loss After Romosozumab/Denosumab: Effects of BisphosphonatesAnne M Horne, Borislav Mihov, Ian R ReidJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 2, 2022
Zoledronate Reduces Height Loss Independently of Vertebral Fracture Occurrence in a Randomized Trial in Osteopenic Older WomenIan R Reid, Sonja Bastin, Anne M Horne, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 12, 2019
Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older WomenIan R Reid, Anne M Horne, Borislav Mihov, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 25, 2020
Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With ZoledronateIan R Reid, Anne M Horne, Borislav Mihov, et al.Pageof 32